Methods for the treatment of IL-1beta related conditions

摘要

Disclosed are methods and materials for inhibiting (e.g., treating or preventing) uveitis in a subject, including treatment refractory uveitis, using anti-IL-1beta binding molecules (e.g., IL-1beta binding antibodies or binding fragment thereof).